Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Recruiting 4Completed 1

Sponsor Class

OTHER 186INDUSTRY 133NIH 19NETWORK 12OTHER_GOV 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Stomach Neoplasms 2Rectal Neoplasms 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Adenocarcinoma 1

Interventions

Capecitabine 9Bevacizumab 8tislelizumab 7Oxaliplatin 7Drug Therapy 7pembrolizumab 6Surgical Procedures, Operative 6Cisplatin 6Standard of Care 5Radiotherapy 5Laparoscopy 5Fluorouracil 5Docetaxel 5Carboplatin 5toripalimab 4Radiosurgery 4Leucovorin 4Exercise 4Epirubicin 4Cyclophosphamide 4pertuzumab 3durvalumab 3dalpiciclib 3atezolizumab 3anlotinib 3Saline Solution 3Rituximab 3Radiation 3Prednisone 3Population Groups 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER_GOV × Fluorouracil × 1 year × Clear all
NCT04864067 2026-05-08

NOAHS-ARC

Servicio de Salud Metropolitano Sur Oriente

Phase 2 Completed
39 enrolled
Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT07542002 2026-04-21

Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory Study

Ningbo Medical Center Lihuili Hospital

Phase 2 Recruiting
37 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06313801 2025-11-21

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

Nizhny Novgorod Regional Clinical Oncology Center

Phase 2 Recruiting
106 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04776655 2025-10-02

LIBImAb

Azienda USL Reggio Emilia - IRCCS

Phase 3 Recruiting
280 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06793917 2025-07-20

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Fujian Cancer Hospital

Phase 3 Recruiting
269 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡